Skip to main content

Animations

MJFF Publications

6041 - 6050 of 9140 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2025
  • Summary Details
    OPEN
    Title: Bridging a mechanistic gap from diet to synapses
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2309992120
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Development and validation of a sensitive sandwich ELISA against human PINK1
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2457915
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Influence of Age on Magnitude and Timing of Vasodepression and Cardioinhibition in Tilt-Induced Vasovagal Syncope
    Journal Name: JACC: Clinical Electrophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.jacep.2022.05.009
    Citation Count: 35
  • Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures
    2023
    Summary Details
    OPEN
    Title: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29608
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad192
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29518
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29375
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon Activation
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.jmb.2023.167999
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885
    Citation Count: 19
  • Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”
    2025
    Summary Details
    RESTRICTED
    Title: Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.30247
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.